Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy

Ryan C. Lynch, MD, Victor A. Chow, MD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD, Mazyar Shadman, MD, Chaitra S. Ujjani, MD, Ryan D. Cassaday, MD, Brian G. Till, MD, Yolanda D. Tseng, MD, Edus H. Warren, MD PhD, Andrei R Shustov, MD, Manoj P. Menon, MD, Elizabeth Loggers, MD PhD, Jenna M. Voutsinas, MPH, Ted Gooley, PhD, Ajay K. Gopal, MD, Stephen D. Smith, MD

Blood (2019) 134 (Supplement_1): 413.

https://doi.org/10.1182/blood-2019-124857

Published: 2019

Journal Articles

Novel Simultaneous Single Cell mRNA and Protein Expression Profiling Identifies Distinct Treg and T Effector Signatures in the Bone Marrow of MDS Patients

Jessica Ann Timms, Susann Winter, Steven Hargreaves, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, Uwe Platzbecker, MD, Shahram Kordasti, MD PhD

Blood (2019) 134 (Supplement_1): 2980.

https://doi.org/10.1182/blood-2019-130355

Published: 2019

Journal Articles

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Viviana Giannuzzi, PhD, Mariagrazia Felisi, PhD, Hugo Devlieger, Aurelio Maggio, MD, George Papanikolaou, MD PhD, Giorgio Reggiardo, Bianca Tempesta, PhD, Fernando Tricta, MD, Donato Bonifazi

Blood (2019) 134 (Supplement_1): 4820.

https://doi.org/10.1182/blood-2019-124689

Published: 2019

Journal Articles

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

Darla K Liles, MD, Rodolfo Cançado, Julie Kanter, MD, Abdullah Kutlar, MD, Andreas Bruederle, Michael Shi, MD PhD, Federico Campigotto, Kenneth I. Ataga

Blood (2018) 132 (Supplement 1): 1082.

https://doi.org/10.1182/blood-2018-99-112201

Published: 2018

Journal Articles

A Feasibility and Usability Study of a Nursing Orchestrated, Customized 3 Dimensional Virtual Reality Environment in Children with Hemophilia Undergoing Routine Intravenous Procedures

Amy L. Dunn, MD, Jeremy Patterson, Charmaine Biega, RN

Blood (2017) 130 (Supplement 1): 3691.

https://doi.org/10.1182/blood.V130.Suppl_1.3691.3691

Published: 2017

Journal Articles

Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea

Joana Marie Mack, MD, Pawel Wiczling, PhD, Joseph Moen, MS, Guolian Kang, PhD, Robert I. Liem, MD MS, Julie A. Panepinto, MD MSPH, Gregory Kearns, PharmD, PhD FCP, FAAP, Kathleen A Neville, MD MS, Jeremie H. Estepp, MD

Blood (2016) 128 (22): 1314.

https://doi.org/10.1182/blood.V128.22.1314.1314

Published: 2016

Journal Articles

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Christina Abrams, MD, Joseph Moen, MS, Guolian Kang, PhD, Winfred C. Wang, MD, Jane Hankins, MD MS, Jeremie H. Estepp, MD

Blood (2016) 128 (22): 125.

https://doi.org/10.1182/blood.V128.22.125.125

Published: 2016

Journal Articles

Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma

Blood (2015) 126 (23): 3961.

https://doi.org/10.1182/blood.V126.23.3961.3961

Published: 2015

Journal Articles

Application Of BOS 0-Potential Criteria As a Predictor For Bronchiolitis Obliterans Syndrome In Allogeneic Stem Cell Transplant Patients

Sameem Abedin, MD, Gregory A. Yanik, MD, John M. Magenau, MD, Steven C. Goldstein, MD, Attaphol Pawarode, MD, John E. Levine, M.D., M.S., Carrie L. Kitko, MD, Daniel R. Couriel, MD

Blood (2013) 122 (21): 2060.

https://doi.org/10.1182/blood.V122.21.2060.2060

Published: 2013

Journal Articles

Pulmonary Clinicopathological Correlation In Long Term Survivors Following Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series

Laura Spring, MD, Lee Gazourian, MD, Lynette Sholl, MD, Jyothi Jagannathan, MD, Emily Meserve, MD, Ami S. Bhatt, MD, PhD, Gerald L. Weinhouse, MD, Victor Pinto-Plata, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Vincent T. Ho, MD, Rebecca M. Baron, MD, George R. Washko, MD

Blood (2013) 122 (21): 2070.

https://doi.org/10.1182/blood.V122.21.2070.2070

Published: 2013

Journal Articles

Urinary Excretion of Epinephrine and Dopamine Correlates with Efficiency of G-CSF Mobilized Stem Cells in Patients with AL Amyloidosis

Heather Landau, MD, Hani Hassoun, MD, James E. Hoffman, MD, Christina Bello, Elizabeth Hoover, Elyn Riedel, Paul S. Frenette, MD, FRCPC, Raymond L. Comenzo, MD

Blood (2011) 118 (21): 316.

https://doi.org/10.1182/blood.V118.21.316.316

Published: 2011

Journal Articles

Comparing MicroRNA Expression In Aggressive and Indolent Non-Hodgkin Lymphomas Identifies a Prognostic Signature for Mantle Cell Lymphoma

Rashmi S. Goswami, BSc, MD, FRCPC, Levi Waldron, Ph.D., Patricia P Reis, Ph.D., Yali Xuan, Wei Xu, Ph.D., John Kuruvilla, David Good, MD, Denis Bailey, MD, Alanna Church, MD, Tara Baetz, MD, David LeBrun, MD, Raymond Lai, MD, Ph.D., Laurie Sehn, MD, MPH, Pedro Farinha, MD, Randy D. Gascoyne, MD, Michael Crump, MD, FRCPC, Igor Jurisica, Ph.D., Suzanne Kamel-Reid, Ph.D.

Blood (2010) 116 (21): 800.

https://doi.org/10.1182/blood.V116.21.800.800

Published: 2010

Journal Articles

Osteoblastic Activation and Response to Velcade® in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Maurizio Zangari, MD, Choon-Kee Lee, MD, Bart Barlogie, MD, PhD, Kevin Najarian, Seung-Hee Kang, MD, Shmuel Yaccoby, PhD, Dixie Esseltine, MD, FRCPC, Julie M. Stover, BA, Guido J. Tricot, MD, PhD

Blood (2004) 104 (11): 4910.

https://doi.org/10.1182/blood.V104.11.4910.4910

Published: 2004

Journal Articles

Improved Immune Reconstitution with Low Incidence of Severe Graft-Versus-Host Disease after Transplantation of CD34 + or CD133 + Enriched Stem Cells with Add-Back of Ten Million T-Cells Per Kg.

Johann Greil, M.D., Peter Lang, M.D., Peter Bader, M.D., Matthias Eyrich, M.D., Paul G. Schlegel, M.D., Michael Schumm, M.D., Tobias Feuchtinger, M.D., Dietrich Niethammer, M.D.

Blood (2004) 104 (11): 1239.

https://doi.org/10.1182/blood.V104.11.1239.1239

Published: 2004

NARROW

Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy

Novel Simultaneous Single Cell mRNA and Protein Expression Profiling Identifies Distinct Treg and T Effector Signatures in the Bone Marrow of MDS Patients

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

A Feasibility and Usability Study of a Nursing Orchestrated, Customized 3 Dimensional Virtual Reality Environment in Children with Hemophilia Undergoing Routine Intravenous Procedures

Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea

Hydroxyurea at Maximal Tolerated Dose (MTD) Prior to Completion of the β-Globin Switch Has Additive but Not Sustained Benefits in Fetal Hemoglobin Production

Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma

Application Of BOS 0-Potential Criteria As a Predictor For Bronchiolitis Obliterans Syndrome In Allogeneic Stem Cell Transplant Patients

Pulmonary Clinicopathological Correlation In Long Term Survivors Following Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series

Urinary Excretion of Epinephrine and Dopamine Correlates with Efficiency of G-CSF Mobilized Stem Cells in Patients with AL Amyloidosis

Comparing MicroRNA Expression In Aggressive and Indolent Non-Hodgkin Lymphomas Identifies a Prognostic Signature for Mantle Cell Lymphoma

Osteoblastic Activation and Response to Velcade® in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Improved Immune Reconstitution with Low Incidence of Severe Graft-Versus-Host Disease after Transplantation of CD34 + or CD133 + Enriched Stem Cells with Add-Back of Ten Million T-Cells Per Kg.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only